Related Experiment Videos
Possible involvement of protease inhibitor ras proteins in malignant transformation
1Division of Biochemistry, Chiba Cancer Center Research Institute, Japan.
Biological Chemistry Hoppe-Seyler
|May 1, 1988
Abstract:
Based on our recent finding that human c-Ha-ras gene products (p21s) inhibit the activities of thiol proteinases, a possible new model for malignant transformation is proposed. The model involves a new concept that p21s can cause effects on the protein kinase activities of growth factor receptors by affecting down regulation of the receptors.
Insights
Human c-Ha-ras gene products (p21s) inhibit thiol proteinases. This finding suggests a new model for malignant transformation involving p21s affecting growth factor receptor kinase activity and downregulation.
Area of Science:
- Oncogenesis
- Molecular Biology
- Biochemistry
Background:
- Human c-Ha-ras gene products (p21s) are known oncoproteins.
- Thiol proteinases play roles in cellular processes.
- Growth factor receptors are critical in cell signaling and cancer.
Purpose of the Study:
- To propose a new model for malignant transformation.
- To investigate the role of p21s in regulating protein kinase activities.
- To explore the mechanism of receptor downregulation by p21s.
Main Methods:
- Investigating the inhibitory effects of p21s on thiol proteinases.
- Analyzing the impact of p21s on growth factor receptor protein kinase activity.
- Studying the downregulation mechanisms of growth factor receptors.
Main Results:
- Demonstrated that human c-Ha-ras gene products (p21s) inhibit thiol proteinase activity.
- Proposed that p21s influence protein kinase activities of growth factor receptors.
- Indicated that p21s affect receptor downregulation.
Conclusions:
- A novel model for malignant transformation is proposed based on p21s activity.
- p21s may regulate cell growth and transformation by modulating growth factor receptor signaling.
- Understanding p21s interactions offers new therapeutic targets for cancer.